FLSM
TARS icon

Frazier Life Sciences Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Frazier Life Sciences Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.1M Hold
728,644
– – 1.32% 18
2025
Q4 		$59.7M Sell
728,644
-438,883
-38% -$32.8M 1.6% 17
2025
Q3 		$69.4M Sell
1,167,527
-230,000
-16% -$11.3M 2.08% 12
2025
Q2 		$56.6M Hold
1,397,527
– – 2.26% 10
2025
Q1 		$71.8M Sell
1,397,527
-190,000
-12% -$9.39M 3.28% 8
2024
Q4 		$87.9M Hold
1,587,527
– – 3.65% 10
2024
Q3 		$52.2M Hold
1,587,527
– – 2.09% 15
2024
Q2 		$43.1M Sell
1,587,527
-200,000
-11% -$6.72M 2.02% 15
2024
Q1 		$65M Hold
1,787,527
– – 2.74% 11
2023
Q4 		$36.2M Hold
1,787,527
– – 1.94% 15
2023
Q3 		$31.8M Hold
1,787,527
– – 2.11% 13
2023
Q2 		$32.3M Hold
1,787,527
– – 1.93% 13
2023
Q1 		$22.5M Hold
1,787,527
– – 1.63% 17
2022
Q4 		$26.2M Hold
1,787,527
– – 1.63% 15
2022
Q3 		$30.6M Hold
1,787,527
– – 2.36% 12
2022
Q2 		$26.1M Buy
1,787,527
+370,370
+26% +$5.56M 2.46% 12
2022
Q1 		$23.8M Buy
+1,417,157
New +$26.3M 2.03% 15

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return